Invention Grant
- Patent Title: Doxorubicin adjuvants to reduce toxicity and methods for using the same
- Patent Title (中): 多柔比星佐剂减少毒性和使用方法
-
Application No.: US12369657Application Date: 2009-02-11
-
Publication No.: US08227517B2Publication Date: 2012-07-24
- Inventor: William A. Garland , Brian D. Frenzel
- Applicant: William A. Garland , Brian D. Frenzel
- Applicant Address: US CA Mountain View
- Assignee: Tosk, Incorporated
- Current Assignee: Tosk, Incorporated
- Current Assignee Address: US CA Mountain View
- Agency: Bozicevic, Field & Francis LLP
- Agent Bret E. Field
- Main IPC: A61K31/095
- IPC: A61K31/095 ; A61K31/10 ; A61K31/105 ; C07C291/00 ; C07C291/08 ; C07C321/22 ; C07C321/24 ; C07C321/26 ; C07C321/28 ; C07C323/08 ; C07C323/09 ; C07C207/00 ; C07C207/04

Abstract:
Methods are provided for using doxorubicin active agents in which reduced host toxicity is observed. Aspects of the methods including administering to a subject an effective amount of a doxorubicin active agent in conjunction with a doxorubicin toxicity-reducing adjuvant, e.g., a nitrone compound, or a nitrone compound in combination with a bisdioxopiperazine compound. Also provided are compositions for use in practicing the subject methods. The methods and compositions find use in a variety of different applications, including in the treatment of a variety of different disease conditions.
Public/Granted literature
- US20090325893A1 DOXORUBICIN ADJUVANTS TO REDUCE TOXICITY AND METHODS FOR USING THE SAME Public/Granted day:2009-12-31
Information query